معرفی
Meiricris Tomaz Da Silva is a Research Scientist in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy. Their work focuses on skeletal muscle biology, particularly the molecular mechanisms governing satellite cell dynamics and muscle wasting in catabolic conditions.
- B.S. and M.S. in Physical Therapy from Methodist University of Piracicaba, Brazil
- Ph.D. in Sciences from the University of São Paulo (USP), Brazil
- Postdoctoral Fellowship at the University of Houston
Their research spans two major areas: (1) identifying signaling pathways that impair satellite cell function in diseases like muscular dystrophies and Marfan syndrome, and (2) uncovering inflammatory/metabolic drivers of muscle atrophy in cancer, denervation, and aging. They employ genetic mouse models and molecular/cellular biology techniques to develop therapeutic strategies for muscle preservation.
Recent publications highlight their exploration of TWEAK/Fn14, IRE1/XBP1, and β2-adrenoceptor pathways in muscle regeneration and wasting. These studies align with broader trends in molecular signaling, regeneration, and targeted interventions to combat catabolic conditions.
- 1st Place, Postdoctoral Oral Presentation (2021 PPS Research Symposium)
- EMBO Travel Grant (2017)
- Travel Grants (Bose Institute, University of Pierre Marie Curie, 2017)
- Qualified Joint CSIR-UGC NET (2011, Rank 65)
- Qualified JNU Entrance Exam (2011)
Meiricris contributes to academic peer-review as a reviewer for journals including iScience, PLOS ONE, and Frontiers in Oncology, and serves on editorial boards for FASEB Journal and Frontiers in Cell and Developmental Biology. They are a member of professional societies such as the American Association of Colleges of Pharmacy and the HEALTH NIMHD-RCMI Addictions Research and Cancer Prevention program.
